We detected distinct plasma concentration profiles of S100B, neuropeptide Y, and secretagogin in 3 of 191 patients enrolled in a previous study investigating brain-tissue-related markers in the blood of patients with atrial fibrillation. Intriguingly, 2 of these 3 patients, both of whom were without neurological symptoms at the time of blood sampling, were diagnosed with malignant glioma (MG) approximately 1 year later. To our knowledge, this is the first report indicating that distinct blood biomarker profiles may be detected long before clinical manifestation of MG. © The Author(s) 2010.
CITATION STYLE
Gartner, W., Ilhan, A., Neziri, D., Base, W., Weissel, M., Wöhrer, A., … Preusser, M. (2010). Elevated blood markers 1 year before manifestation of malignant glioma. Neuro-Oncology, 12(9), 1004–1008. https://doi.org/10.1093/neuonc/noq034
Mendeley helps you to discover research relevant for your work.